IDMoS aims for £2m in share placing:
This article was originally published in Clinica
IDMoS (Dundee, Scotland), a specialist in producing disease detection and monitoring technology, is expecting to raise £2m ($3.98m) before expenses through the conditional placing of around 5.25 million shares at 35p per share. The financing is conditional, on admission of the shares trading on the UK AIM stock exchange and the approval by shareholders of certain resolutions. The company intends to use the proceeds for the launch of its dental decay detection and monitoring products, the Caries Detection Device (CDD) and its Caries Management Support System (CMSS), which are expected to go on sale in the US and European markets later this year.